Creative Medical Technology Holdings Inc CELZ
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2009-05-01 |
| Shares Out. | 4,740,000 |
| Website | creativemedicaltechnology.com/ ↗ |
| Phone | 14803992822 |
| Employees | 4 |
| Net Income | -$1.4M |
| Total Assets | $6.4M |
| Total Liabilities | $307,649 |
| Equity | $6.1M |
About Creative Medical Technology Holdings Inc
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
Creative Medical Technology Holdings Inc is a publicly traded company under the ticker symbol CELZ on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2026-07-01)